Treatment Delay for Lung Cancer Patients
Raymond Osarogiagbon, MBBS and Nicolas Faris, MDiv led a group of researchers from Baptist Cancer Center and the University of Memphis in Tennessee, who reviewed hospital records for all patients who underwent surgery for suspected lung cancer at Baptist Memorial Hospital between January 2009 and June 2013. They wanted to know how much time it takes to begin care and what steps are taken to determine appropriate treatment for these patients.
“It takes too long for patients who have suspected lung cancer to get final treatment, and too many patients skip vital steps needed to decide the best possible treatment,” Dr. Osarogiagbon points out. “This delay in treatment can cause the cancer to advance and reduce the odds of survival for the patient.”
Of the 614 eligible patients included in the analysis, 27 percent had no preoperative diagnostic procedure, 22 percent did not have an imaging scan to stage the cancer, and 88 percent did not have an invasive staging test. Notably, only 1 in 10 patients (10 percent) had the recommended combination of three staging tests — computed tomography (CT) scan, positron emission tomography (PET)/CT scan, and an invasive test — before surgery.
Overall, results also showed that it took a month and a half to more than six months for many patients to undergo surgery after an initial x-ray displayed signs of possible lung cancer.
“Lung cancer care is complicated, and all key specialists must be actively engaged early on with each patient to determine the best sequence of tests and treatment for each individual,” Dr. Osarogiagbon says.
Faris also notes that quality matters at every step in the lung cancer treatment process. “Patients should feel comfortable taking an active role in their treatment process and ask a lot of questions — find out what treatment is right for them, why that option is the best, and what steps they can take to be better prepared for treatment,” he says.
The study is part of an ongoing prospective process-of-care analysis to examine factors associated with deviation from optimal care delivery for both surgical and non-surgical patients.
Source: Society of Thoracic Surgeons
Image credit: Pixabay
Published on : Thu, 30 Jul 2015
The best patient care is your ultimate goal. To achieve this requires confident diagnosis even with daily increases in patient throughput. Built on the foundation of Mindray’s continuous customer insights into clinical needs and the inheritance from...
We recognize that the best chance any patient has at getting better is a clinician at their bedside with all the right answers and the confidence to act. SonoSite education and training is the industry standard – no other point-of-care ultrasound manufacturer...
Powered by the most revolutionary ZONE Sonography® Technology, Resona 7’s new ZST+ platform brings the ultrasound image quality to a higher level by zone acquisition and channel data processing. Resona 7 also provides clinical research with the revolutionary...
UltraDrape is an innovative dressing designed for use during Ultrasound-Guided Peripheral Intravenous (UGPIV) that provides dual-action barrier and securement in one.
Explore the new dimension that you have never seen before WS80A with Elite is designed to create a new possibility for ultrasound diagnosis adopting new dimension that you have never seen before. The finest image quality, advanced 5D diagnostic solution...